Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Immunosuppressive Protein Signatures Carried by Syncytiotrophoblast-Derived Exosomes and Their Role in Human Pregnancy
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi.
2021 (engelsk)Inngår i: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 12, artikkel-id 717884Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

The syncytiotrophoblast (STB) of human placenta constitutively and throughout pregnancy produces and secretes exosomes - nanometer-sized membrane-bound extracellular vesicles from the endosomal compartment that convey cell-cell contact ‘by proxy’ transporting information between donor and recipient cells locally and at a distance. Released in the maternal blood, STB-derived exosomes build an exosomal gradient around the feto-placental unit acting as a shield that protects the fetus from maternal immune attack. They carry signal molecules and ligands that comprise distinct immunosuppressive protein signatures which interfere with maternal immune mechanisms, potentially dangerous for the ongoing pregnancy. We discuss three immunosuppressive signatures carried by STB exosomes and their role in three important immune mechanisms 1) NKG2D receptor–mediated cytotoxicity, 2) apoptosis of activated immune cells and 3) PD-1-mediated immunosuppression and priming of T regulatory cells. A schematic presentation is given on how these immunosuppressive protein signatures, delivered by STB exosomes, modulate the maternal immune system and contribute to the development of maternal-fetal tolerance.

sted, utgiver, år, opplag, sider
Frontiers Media S.A., 2021. Vol. 12, artikkel-id 717884
Emneord [en]
exosomes, human placenta, immune suppression, maternal-fetal tolerance, pregnancy
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-186716DOI: 10.3389/fimmu.2021.717884ISI: 000682934400001PubMedID: 34381459Scopus ID: 2-s2.0-85112200314OAI: oai:DiVA.org:umu-186716DiVA, id: diva2:1591133
Forskningsfinansiär
Swedish Cancer Society, 2018/350Tilgjengelig fra: 2021-09-06 Laget: 2021-09-06 Sist oppdatert: 2024-01-17bibliografisk kontrollert

Open Access i DiVA

fulltext(4540 kB)242 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 4540 kBChecksum SHA-512
64fdad7398f6c5e60883c52422d5749a5847c9700d470c24c3be3c86871cec1d1ab4281f4e2a38d1cec984d987b9195f5d891e03182b4198129d3a5bd7b678e3
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Mincheva-Nilsson, Lucia

Søk i DiVA

Av forfatter/redaktør
Mincheva-Nilsson, Lucia
Av organisasjonen
I samme tidsskrift
Frontiers in Immunology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 243 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 427 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf